News

research

The chief scientific officer and medical director of Segal Trials shares more on KarXT, a first in class for muscarinic agonists, and what he's excited about at the upcoming 2024 APA Annual Meeting.

spring

"Otherwise it's spring, and everything looks frail; the sky is baby blue, and the just-unfurling leaves are full of infant chlorophyll, the very tint of inexperience."